Which hedge funds own ORIC? ORIC PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in ORIC (ORIC PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $190.3m in total. The largest holder by portfolio weight is Alkeon Capital Management at 0.3% of its book. 1 exited: Moore Capital Management.
8tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold ORIC? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Alkeon Capital Management | Q2 2026 | 0.3% | $67.7m | 3,739,096 | -17% | reduced |
| Viking Global Investors | Q2 2026 | 0.2% | $55.5m | 5,126,762 | -12% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $13.5m | 1,247,515 | 0% | held |
| Citadel Advisors | Q2 2026 | 0.0% | $28.1m | 2,595,299 | 7% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $17.1m | 1,580,216 | 3460% | added |
| Millennium Management | Q2 2026 | 0.0% | $7.6m | 697,694 | 1951% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $332.0k | 30,654 | 56% | added |
| Tudor Investment | Q2 2026 | 0.0% | $459.3k | 42,409 | 26% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Moore Capital Management | 0.1% | $754.7k |
How has hedge fund ownership of ORIC changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $190.3m |
| Q1 2026 | 9 | $217.8m |
| Q4 2025 | 5 | $145.8m |
| Q3 2025 | 5 | $131.5m |
| Q2 2025 | 6 | $174.7m |
| Q1 2025 | 4 | $75.6m |
| Q4 2024 | 3 | $98.5m |
| Q3 2024 | 4 | $122.7m |
| Q2 2024 | 4 | $38.0m |
| Q1 2024 | 4 | $141.9m |
| Q4 2023 | 3 | $17.6m |
| Q3 2023 | 2 | $9.2m |
| Q2 2023 | 3 | $45.1m |
| Q1 2023 | 4 | $35.8m |
| Q4 2022 | 4 | $17.7m |
| Q3 2022 | 4 | $9.5m |
Counts every tracked manager that disclosed ORIC in that quarter's filing, including managers that have since stopped filing.